Cigna Group (NYSE:CI) Stock Has Average Price Target of $337.10

Cigna Group (NYSE:CI) has been assigned an average rating of “Moderate Buy” from the twenty-three analysts that are covering the firm, Marketbeat Ratings reports. Eight equities research analysts have rated the stock with a hold recommendation and fifteen have assigned a buy recommendation to the company. The average 12 month price objective among brokers that have issued a report on the stock in the last year is $338.24.

A number of research firms have issued reports on CI. Evercore assumed coverage on shares of Cigna Group in a research report on Wednesday, September 9th. They issued an “in-line” rating and a $290.00 target price for the company. Wall Street Zen upgraded shares of Cigna Group from a “hold” rating to a “buy” rating in a research note on Saturday, September 26th. Jefferies Financial Group cut Cigna Group from a “buy” rating to a “hold” rating and cut their price objective for the company from $336.00 to $307.00 in a report on Tuesday, August 4th. Wells Fargo & Company raised their price target on shares of Cigna Group from $305.00 to $307.00 and gave the company an “equal weight” rating in a report on Friday, July 31st. Finally, Mizuho lifted their price objective on Cigna Group from $330.00 to $340.00 and gave the stock an “outperform” rating in a research report on Monday, June 8th.

Insider Buying and Selling

In other Cigna Group news, insider Everett Neville sold 617 shares of the stock in a transaction on Thursday, September 3rd. The shares were sold at an average price of $284.05, for a total value of $175,258.85. Following the completion of the sale, the insider owned 5,053 shares in the company, valued at $1,435,304.65. This trade represents a 10.88% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nicole Jones sold 2,677 shares of the business’s stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $279.61, for a total value of $748,515.97. Following the transaction, the insider directly owned 25,880 shares in the company, valued at approximately $7,236,306.80. This trade represents a 9.37% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders have sold 22,730 shares of company stock worth $6,293,359. Company insiders own 0.60% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in CI. Assetmark Inc. increased its position in Cigna Group by 10.0% in the 1st quarter. Assetmark Inc. now owns 65,662 shares of the health services provider’s stock valued at $17,515,000 after buying an additional 5,963 shares in the last quarter. Mystic Asset Management Inc. bought a new stake in shares of Cigna Group during the 2nd quarter worth $2,808,000. KBC Group NV lifted its holdings in Cigna Group by 6.4% during the second quarter. KBC Group NV now owns 380,034 shares of the health services provider’s stock valued at $104,768,000 after purchasing an additional 22,978 shares during the last quarter. Sanctuary Advisors LLC bought a new stake in shares of Cigna Group in the second quarter valued at approximately $11,043,000. Finally, Nykredit A S purchased a new stake in shares of Cigna Group during the 2nd quarter valued at approximately $15,300,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

Cigna Group Stock Performance

Cigna Group stock opened at $270.92 on Wednesday. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.76 and a current ratio of 0.76. The stock’s 50 day moving average price is $278.79 and its 200 day moving average price is $280.50. The firm has a market capitalization of $71.59 billion, a PE ratio of 11.21, a price-to-earnings-growth ratio of 0.90 and a beta of 0.29. Cigna Group has a one year low of $239.51 and a one year high of $315.47.

Cigna Group (NYSE:CI) last issued its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 EPS for the quarter, topping the consensus estimate of $7.60 by $0.18. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The business had revenue of $71.56 billion for the quarter, compared to analysts’ expectations of $70.14 billion. During the same quarter last year, the company posted $7.20 earnings per share. The company’s quarterly revenue was up 6.7% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, sell-side analysts expect that Cigna Group will post 30.51 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th were given a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a dividend yield of 2.3%. The ex-dividend date of this dividend was Tuesday, September 8th. Cigna Group’s dividend payout ratio is currently 25.82%.

About Cigna Group

The Cigna Group (NYSE: CI) is a global health company that provides health care and related services to individuals, employers, government organizations and health plans. Its operations are primarily organized through Cigna Healthcare and Evernorth Health Services, which together address health coverage, pharmacy services, care delivery and benefit management.

Cigna Healthcare offers medical, dental, behavioral health, disability and other benefits, with a focus on employer-sponsored and individual health plans in the United States as well as international health services.